About Cephazone Pharma LLC
Cephazone Pharma LLC is a Pharmaceuticals company, headquartered in Pomona, with 11 - 50 employees and annual revenue of $50M - $100M.
Cephazone Pharma LLC develops and manufactures generics of specialized chemicals in various dosage forms. Cephazone provides excellence in quality, efficiency and technology for the pharmaceutical industry as well as the patient, the ultimate consumer of our products. Cephazone Pharma LLC was establ...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Cephazone Pharma LLC Company Highlights
Phone Number
(909) 392-xxxx
Corporate Office Address
250 East Bonita Avenue
Pomona, 91767
Website
Cephazone Pharma LLC Org
Cephazone Pharma LLC has 3 Director, 2 Manager, and 2 Other employees.
Cephazone Pharma LLC's Tech Stack
Frequently Asked Questions About
Cephazone Pharma LLC
Log in or sign up to get full contact details and additional support.
How many senior employees does Cephazone Pharma LLC have?
Cephazone Pharma LLC has 5 senior employees that are typically used for decision making.
How do I contact Cephazone Pharma LLC?
To contact Cephazone Pharma LLC, visit cephazone.com.
What companies are similar to Cephazone Pharma LLC?
Companies similar to Cephazone Pharma LLC include Kyowa Kirin Inc., Pharma Connections Worldwide Inc., and US Bioservices.
Where is Cephazone Pharma LLC headquartered?
Cephazone Pharma LLC is headquartered at 250 East Bonita Avenue, Pomona.
What is the main phone number for Cephazone Pharma LLC?
The main phone number for Cephazone Pharma LLC is (909) 392-xxxx.
What is the official website for Cephazone Pharma LLC?
The official website for Cephazone Pharma LLC is cephazone.com.
What is the annual revenue of Cephazone Pharma LLC?
The annual revenue of Cephazone Pharma LLC is $50M - $100M.
How many employees does Cephazone Pharma LLC have?
Cephazone Pharma LLC has 11 - 50 employees.
What industry is Cephazone Pharma LLC in?
Cephazone Pharma LLC is in the Pharmaceuticals industry.
Last updated: May 28, 2025